Stockreport

Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook [Yahoo! Finance]

Ligand Pharmaceuticals Incorporated  (LGND) 
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.ligand.com
PDF to TREMFYA litigation (Ligand would receive 25% of any net proceeds after legal costs), with the deal expected to close in Q3 2026 and be "immediately accretive" to earn [Read more]